Indication

Pneumococcal pharyngitis

Pneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae*. Read more about Pneumococcal pharyngitis

59 drugs 30 manufacturers

Advertisement

Drugs that treat it

Common Pneumococcal pharyngitis therapies.

Showing 55–59 of 59 drugs

Filter & compare in the drug finder →Opens the drug finder with Pneumococcal pharyngitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pneumococcal pharyngitis.

Pneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae*.

Although *Streptococcus pneumoniae* frequently colonizes the human nasopharynx as a commensal organism, it only rarely acts as a primary pathogen of the pharyngeal mucosa, occurring across pediatric and adult populations.

Pathophysiologically, the condition involves local bacterial adherence and tissue invasion, manifesting clinically with pharyngeal erythema, localized throat pain, tonsillar swelling, dysphagia, and occasionally low-grade fever or cervical lymphadenopathy.

In standard clinical practice, *S.

pneumoniae* is not widely recognized as an established or guideline-defined standalone indication for pharyngitis, making this phrase an uncommon clinical designation primarily documented in isolated case reports rather than an approved therapeutic indication.

Personalize your experience

Follow Pneumococcal pharyngitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it